STLN Starling Oncology, Inc.
Nasdaq · SEC CIK 1799191 · EDGAR
- Bought, last 12 months
- $2.69M 13 purchases by 1 insiders
- Sold, last 12 months
- $2.81M 7 sales by 5 insiders
- Filings on record
- 228 since 2021-11-16, latest 2026-08-24 17:11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Chernett Jorey | 10% | $2.69M | — |
| Hively Brad | Dir | — | $2.00M |
| Kaushal Mohit | Dir | — | $335.1K |
| Podnos Yale | Chief Medical Off | — | $276.4K |
| Pacala Mark L | Dir | — | $200.0K |
| Carter Robert Ross | CFO | — | $879.32 |
| England Kristin | Chief Administrative Off | — | — |
| Langsam Jeffrey | Chief Clinical Off | — | — |
| Ling Gabriel | Dir | — | — |
| TOI M, LLC | Dir | — | — |
Transactions 242
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-24 17:11 | 2026-08-21 | STLN | Hively Brad | Dir | S - Sale | $6.51 | -298.9K | 412.0K | -42% | -$1.95M |
| D | 2026-08-17 10:13 | 2026-08-14 | STLN | Chernett Jorey | 10% | P - Purchase | $6.54 | +12.0K | 10.66M | +0.1% | +$78.5K |
| 2026-07-29 18:56 | 2026-07-27 | STLN | Kaushal Mohit | Dir | A - Grant | $0.00 | +33.1K | 205.7K | +19% | $0 | |
| 2026-07-29 18:54 | 2026-07-27 | STLN | McGeorge Anne | Dir | A - Grant | $0.00 | +41.2K | 332.5K | +14% | $0 | |
| 2026-07-29 18:53 | 2026-07-27 | STLN | Pacala Mark L | Dir | A - Grant | $0.00 | +30.1K | 286.9K | +12% | $0 | |
| 2026-07-29 18:52 | 2026-07-27 | STLN | STOLPER MARK | Dir | A - Grant | $0.00 | +31.1K | 57.0K | +120% | $0 | |
| 2026-07-29 18:50 | 2026-07-27 | STLN | TZOUMAKAS KIMBERLY JO | Dir | A - Grant | $0.00 | +29.1K | 46.3K | +169% | $0 | |
| 2026-07-29 18:49 | 2026-07-27 | STLN | Hively Brad | Dir | A - Grant | $0.00 | +27.1K | 710.8K | +4% | $0 | |
| 2026-07-29 18:46 | 2026-07-27 | STLN | Johnson Karen Marie | Dir | A - Grant | $0.00 | +31.1K | 319.4K | +11% | $0 | |
| 2026-07-22 09:55 | 2026-07-21 | STLN | Chernett Jorey | 10% | P - Purchase | $5.27 | +18.0K | 10.65M | +0.2% | +$94.9K | |
| DMT | 2026-07-16 20:05 | 2026-07-14 | STLN | Podnos Yale | Chief Medical Off | M - OptEx | $1.90 | +23.5K | 265.0K | +10% | +$44.6K |
| DMT | 2026-07-16 20:05 | 2026-07-14 | STLN | Podnos Yale | Chief Medical Off | S - Sale+OE | $6.41 | -23.5K | 259.5K | -8% | -$150.3K |
| 2026-07-13 11:34 | 2026-07-10 | STLN | Chernett Jorey | 10% | P - Purchase | $5.85 | +15.0K | 10.63M | +0.1% | +$87.8K | |
| 2026-07-09 16:30 | 2026-07-07 | STLN | TZOUMAKAS KIMBERLY JO | Dir | A - Grant | $0.00 | +17.2K | 17.2K | New | $0 | |
| 2026-07-09 16:30 | 2026-07-07 | STLN | STOLPER MARK | Dir | A - Grant | $0.00 | +25.8K | 25.8K | New | $0 | |
| 2026-06-24 09:31 | 2026-06-23 | STLN | Chernett Jorey | 10% | P - Purchase | $5.02 | +18.0K | 10.62M | +0.2% | +$90.4K | |
| T | 2026-06-09 19:06 | 2026-06-08 | STLN | Podnos Yale | Chief Medical Off | S - Sale | $5.38 | -23.5K | 259.5K | -8% | -$126.1K |
| 2026-06-05 09:38 | 2026-06-04 | STLN | Chernett Jorey | 10% | P - Purchase | $4.75 | +12.0K | 10.58M | +0.1% | +$57.0K | |
| 2026-05-22 17:39 | 2026-05-21 | STLN | Podnos Yale | Chief Medical Off | J - Other | $4.47 | -1,805 | 283.0K | -0.6% | -$8,068 | |
| 2026-05-22 17:37 | 2026-05-21 | STLN | Virnich Daniel | CEO | J - Other | $4.47 | -23.1K | 2.34M | -1.0% | -$103.1K | |
| 2026-05-22 17:32 | 2026-05-21 | STLN | Carter Robert Ross | CFO | J - Other | $4.47 | -1,604 | 414.8K | -0.4% | -$7,170 | |
| M | 2026-05-21 09:35 | 2026-05-19+ | STLN | Chernett Jorey | 10% | P - Purchase | $4.07 | +38.5K | 10.57M | +0.4% | +$156.6K |
| 2026-05-20 12:25 | 2026-05-19 | STLN | Chernett Jorey | 10% | P - Purchase | $4.09 | +30.0K | 10.53M | +0.3% | +$122.7K | |
| MT | 2026-04-16 19:27 | 2026-04-14+ | STLN | Kaushal Mohit | Dir | S - Sale | $3.50 | -95.7K | 172.6K | -36% | -$335.1K |
| 2026-04-13 09:03 | 2026-04-09 | STLN | Chernett Jorey | 10% | P - Purchase | $3.10 | +20.0K | 10.50M | +0.2% | +$62.0K | |
| 2026-04-01 21:00 | 2026-03-27 | STLN | Langsam Jeffrey | Chief Clinical Off | A - Grant | $0.00 | +70.3K | 127.7K | +122% | $0 | |
| 2026-04-01 20:57 | 2026-03-27 | STLN | England Kristin | Chief Administrative Off | A - Grant | $0.00 | +55.7K | 153.8K | +57% | $0 | |
| 2026-04-01 20:51 | 2026-03-27 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +66.4K | 301.0K | +28% | $0 | |
| 2026-04-01 20:51 | 2026-03-27 | STLN | Podnos Yale | Chief Medical Off | J - Other | $3.07 | -16.2K | 284.8K | -5% | -$49.7K | |
| 2026-04-01 20:47 | 2026-03-27 | STLN | Carter Robert Ross | CFO | A - Grant | $0.00 | -202.9K | 436.7K | -32% | $0 | |
| 2026-04-01 20:47 | 2026-03-27 | STLN | Carter Robert Ross | CFO | J - Other | $3.07 | -20.3K | 416.4K | -5% | -$62.4K | |
| 2026-04-01 20:46 | 2026-03-27 | STLN | Virnich Daniel | CEO | A - Grant | $0.00 | -670.6K | 2.46M | -21% | $0 | |
| 2026-04-01 20:46 | 2026-03-27 | STLN | Virnich Daniel | CEO | J - Other | $3.07 | -98.5K | 2.36M | -4% | -$302.5K | |
| 2026-03-30 | 2026-03-27 | STLN | Chernett Jorey | 10% | P - Purchase | $2.96 | +27.4K | 10.48M | +0.3% | +$81.2K | |
| 2026-03-27 | 2026-03-26 | STLN | Chernett Jorey | 10% | P - Purchase | $3.15 | +50.0K | 10.45M | +0.5% | +$157.5K | |
| 2026-03-25 | 2026-03-24 | STLN | Chernett Jorey | 10% | P - Purchase | $3.11 | +125.0K | 10.40M | +1% | +$388.8K | |
| 2026-03-23 | 2026-03-20 | STLN | Chernett Jorey | 10% | P - Purchase | $3.35 | +25.0K | 10.28M | +0.2% | +$83.8K | |
| 2026-03-18 | 2026-03-17 | STLN | Virnich Daniel | CEO | J - Other | $3.59 | -11.8K | 1.79M | -0.7% | -$42.5K | |
| 2026-03-18 | 2026-03-17 | STLN | Podnos Yale | Chief Medical Off | J - Other | $3.59 | -3,420 | 234.5K | -1% | -$12.3K | |
| 2026-03-18 | 2026-03-17 | STLN | Carter Robert Ross | CFO | J - Other | $3.59 | -1,314 | 233.8K | -0.6% | -$4,717 | |
| M | 2026-03-17 | 2026-03-13+ | STLN | Chernett Jorey | 10% | P - Purchase | $3.07 | +399.0K | 10.25M | +4% | +$1.23M |
| A | 2026-01-06 | 2026-01-02 | STLN | Carter Robert Ross | CFO | J - Other | $3.67 | -244 | 235.1K | -0.1% | -$895.48 |
| 2026-01-05 | 2026-01-02 | STLN | Carter Robert Ross | CFO | S - Sale | $3.56 | -247 | 235.1K | -0.1% | -$879.32 | |
| 2025-12-16 | 2025-12-15 | STLN | Hively Brad | Dir | S - Sale | $3.77 | -13.3K | 683.7K | -2% | -$50.3K | |
| M | 2025-11-24 | 2025-11-20 | STLN | Kaushal Mohit | Dir | A - Grant | $0.00 | +91.0K | 228.2K | +66% | $0 |
| M | 2025-11-24 | 2025-11-20 | STLN | Pacala Mark L | Dir | A - Grant | $0.00 | +81.8K | 221.3K | +59% | $0 |
| M | 2025-11-24 | 2025-11-20 | STLN | Johnson Karen Marie | Dir | A - Grant | $0.00 | +84.9K | 251.2K | +51% | $0 |
| M | 2025-11-24 | 2025-11-20 | STLN | Hively Brad | Dir | A - Grant | $0.00 | +74.1K | 664.6K | +13% | $0 |
| M | 2025-11-24 | 2025-11-20 | STLN | Ling Gabriel | Dir | A - Grant | $0.00 | +83.3K | 296.5K | +39% | $0 |
| M | 2025-11-24 | 2025-11-20 | STLN | McGeorge Anne | Dir | A - Grant | $0.00 | +108.0K | 291.4K | +59% | $0 |
| 2025-11-20 | 2025-11-18 | STLN | Ling Gabriel | Dir | J - Other | — | +141.1K | 250.2K | +129% | — | |
| M | 2025-11-20 | 2025-11-18 | STLN | TOI M, LLC | Dir | J - Other | — | -2.49M | 7.94M | -24% | — |
| I | 2025-11-20 | 2025-11-18 | STLN | TOI M, LLC | Dir | J - Other | — | -590.9K | 0 | -100% | — |
| M | 2025-11-20 | 2025-11-18 | STLN | Pacala Mark L | Dir | S - Sale | $4.00 | -50.0K | 221.6K | -18% | -$200.0K |
| 2025-11-19 | 2025-11-17 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +2,086 | 237.9K | +0.9% | $0 | |
| 2025-11-19 | 2025-11-17 | STLN | Carter Robert Ross | CFO | A - Grant | $0.00 | +195 | 235.4K | +0.1% | $0 | |
| 2025-11-19 | 2025-11-17 | STLN | Virnich Daniel | CEO | A - Grant | $0.00 | +6,464 | 1.80M | +0.4% | $0 | |
| M | 2025-11-14 | 2025-11-12 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +1,508 | 235.8K | +0.6% | $0 |
| 2025-11-14 | 2025-11-12 | STLN | Virnich Daniel | CEO | A - Grant | $0.00 | +6,211 | 1.79M | +0.3% | $0 | |
| I | 2025-09-05 | 2025-09-04 | STLN | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.09 | -681.8K | 590.9K | -54% | -$2.11M |
| 2025-09-05 | 2025-09-04 | STLN | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.09 | -6.02M | 7.93M | -43% | -$18.60M | |
| 2025-08-21 | 2025-08-19 | STLN | Hively Brad | Dir | S - Sale | $4.06 | -20.2K | 623.0K | -3% | -$82.1K | |
| I | 2025-07-28 | 2025-07-24 | STLN | BARASCH RICHARD A | Dir | J - Other | $0.00 | -287.8K | 2.64M | -10% | $0 |
| 2025-07-24 | 2025-07-22 | STLN | England Kristin | Chief Administrative Off | A - Grant | $0.00 | +98.0K | 98.0K | New | $0 | |
| DI | 2025-06-24 | 2025-06-17 | STLN | BARASCH RICHARD A | Dir | F - Tax | $2.62 | -311.1K | 2.92M | -10% | -$815.2K |
| DI | 2025-06-24 | 2025-06-17 | STLN | BARASCH RICHARD A | Dir | X - OptEx | $1.20 | +679.2K | 3.23M | +27% | +$815.1K |
| D | 2025-06-20 | 2025-06-17 | STLN | BARASCH RICHARD A | Dir | C - Cnv Deriv | $0.00 | +159.5K | 1.94M | +9% | $0 |
| DI | 2025-06-20 | 2025-06-18 | STLN | BARASCH RICHARD A | Dir | C - Cnv Deriv | $0.00 | +620.4K | 2.56M | +32% | $0 |
| 2025-06-09 | 2025-06-05 | STLN | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.05 | -673.7K | 13.95M | -5% | -$2.05M | |
| I | 2025-06-09 | 2025-06-05 | STLN | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.05 | -76.3K | 1.27M | -6% | -$232.8K |
| DM | 2025-06-05 | 2025-06-03 | STLN | Hively Brad | Dir | S - Sale+OE | $2.87 | -1.98M | 712.0K | -74% | -$5.67M |
| DM | 2025-06-05 | 2025-06-03 | STLN | Hively Brad | Dir | M - OptEx | $0.9008 | +1.87M | 1.40M | New | +$1.68M |
| 2025-05-23 | 2025-05-21 | STLN | Langsam Jeffrey | Chief Clinical Off | A - Grant | $0.00 | +57.4K | 57.4K | New | $0 | |
| 2025-05-22 | 2025-05-21 | STLN | Carter Robert Ross | CFO | D - Sale to Iss | $2.68 | -1,601 | 235.2K | -0.7% | -$4,291 | |
| 2025-05-22 | 2025-05-21 | STLN | Castle Jeremy | COO | D - Sale to Iss | $2.68 | -5,636 | 247.0K | -2% | -$15.1K | |
| 2025-05-22 | 2025-05-21 | STLN | Podnos Yale | Chief Medical Off | D - Sale to Iss | $2.68 | -1,801 | 234.3K | -0.8% | -$4,827 | |
| 2025-05-22 | 2025-05-21 | STLN | Virnich Daniel | CEO | D - Sale to Iss | $2.68 | -20.4K | 1.79M | -1% | -$54.6K | |
| 2025-05-22 | 2025-05-20 | STLN | M33 Growth I GP LLC | Dir, 10% | S - Sale | $2.71 | -1.80M | 14.62M | -11% | -$4.87M | |
| I | 2025-05-22 | 2025-05-20 | STLN | M33 Growth I GP LLC | Dir, 10% | S - Sale | $2.71 | -203.5K | 1.35M | -13% | -$551.6K |
| DA | 2025-04-28 | 2025-03-26 | STLN | Hively Brad | Dir | P - Purchase | $1.04 | +45.3K | 712.0K | +7% | +$47.1K |
| 2025-04-02 | 2025-03-31 | STLN | Castle Jeremy | COO | A - Grant | $0.00 | +162.3K | 252.7K | +180% | $0 | |
| 2025-04-02 | 2025-03-31 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +157.1K | 236.1K | +199% | $0 | |
| 2025-04-02 | 2025-03-31 | STLN | Carter Robert Ross | CFO | A - Grant | $0.00 | +197.4K | 236.8K | +501% | $0 | |
| 2025-04-02 | 2025-03-31 | STLN | Virnich Daniel | CEO | A - Grant | $0.00 | +1.08M | 1.81M | +150% | $0 | |
| D | 2025-03-28 | 2025-03-26 | STLN | Johnson Karen Marie | Dir | P - Purchase | $1.04 | +36.2K | 203.4K | +22% | +$37.7K |
| D | 2025-03-28 | 2025-03-26 | STLN | Podnos Yale | Chief Medical Off | P - Purchase | $1.04 | +9,056 | 79.0K | +13% | +$9,418 |
| D | 2025-03-28 | 2025-03-26 | STLN | Virnich Daniel | CEO | P - Purchase | $1.04 | +22.6K | 724.4K | +3% | +$23.5K |
| D | 2025-03-28 | 2025-03-26 | STLN | Hively Brad | Dir | P - Purchase | $1.04 | +9,056 | 675.8K | +1% | +$9,418 |
| DI | 2025-03-28 | 2025-03-26 | STLN | BARASCH RICHARD A | Dir | P - Purchase | $1.04 | +1.36M | 1.78M | +326% | +$1.41M |
| DI | 2025-03-28 | 2025-03-26 | STLN | Pacala Mark L | Dir | P - Purchase | $1.04 | +90.6K | 225.0K | +67% | +$94.2K |
| D | 2025-03-28 | 2025-03-26 | STLN | M33 Growth I L.P. | Dir, 10% | A - Grant | $1.04 | +2.72M | 16.42M | +20% | +$2.83M |
| D | 2025-03-28 | 2025-03-26 | STLN | Carter Robert Ross | CFO | P - Purchase | $1.04 | +9,056 | 39.4K | +30% | +$9,418 |
| D | 2025-03-28 | 2025-03-26 | STLN | Castle Jeremy | COO | P - Purchase | $1.04 | +9,056 | 90.4K | +11% | +$9,418 |
| 2025-03-20 | 2025-03-19 | STLN | Virnich Daniel | CEO | D - Sale to Iss | $0.89 | -10.3K | 701.7K | -1% | -$9,132 | |
| 2025-03-20 | 2025-03-19 | STLN | Carter Robert Ross | CFO | D - Sale to Iss | $0.89 | -1,150 | 30.4K | -4% | -$1,024 | |
| 2025-03-20 | 2025-03-19 | STLN | Podnos Yale | Chief Medical Off | D - Sale to Iss | $0.89 | -2,975 | 70.0K | -4% | -$2,648 | |
| 2025-01-07 | 2025-01-06 | STLN | Carter Robert Ross | CFO | D - Sale to Iss | $0.34 | -258 | 31.5K | -0.8% | -$87.72 | |
| 2024-12-05 | 2024-12-03 | STLN | Castle Jeremy | COO | D - Sale to Iss | $0.16 | -1,130 | 81.3K | -1% | -$180.80 | |
| M | 2024-12-02 | 2024-11-26+ | STLN | Hively Brad | Dir | P - Purchase | $0.1667 | +300.0K | 616.8K | +95% | +$50.0K |
| 2024-12-02 | 2024-11-12 | STLN | Hively Brad | Dir | J - Other | $0.00 | -353.4K | 366.8K | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations